Nuvectis Pharma Inc (NAS:NVCT)
$ 4.97 0.05 (1.02%) Market Cap: 96.03 Mil Enterprise Value: 77.89 Mil PE Ratio: 0 PB Ratio: 8.50 GF Score: 22/100

Nuvectis Pharma Inc To Host Virtual Event Transcript

Sep 14, 2023 / 02:00PM GMT
Release Date Price: $14.02 (+0.79%)
Operator

Good morning, and welcome to the Nuvectis KOL event. (Operator Instructions)

As a reminder, this call is being recorded and a replay will be made available on the Nuvectis website following the conclusion of the event.

I'd now like to turn the call over to Ron Bentsur, Chairman and Chief Executive Officer of Nuvectis Pharma. Please go ahead, Ron.

Ron Bentsur
Nuvectis Pharma, Inc. - Chairman, CEO, & President

Thank you very much, Terra. And thank you all for tuning in, we really appreciate your time this morning. And I particularly want to thank the KOLs who are with us today. The tech team, I need slide control please. Thank you.

So with us -- and by the way, I can probably take up the entire time of the call today just to talk about the credentials of the KOLs that are on this call. But obviously, I'm happy to be a little bit more succinct. So in a nutshell, we have a three a world-renowned KOLs each in his respective field.

So the first one to speak will be Doctor Bradley Monk, who's at the University of Arizona and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot